Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for autoimmune non-infectious uveitis
ISRCTN31474800Phase 4Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 4, randomised, double-blind trial of adalimumab in uveitis (3 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Time to first treatment failure. Started Dec 2020; status: completed.
02
Drugs
03
Conditions
uveitis
Beyond the preview
Go deeper on ISRCTN31474800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31474800.